Results
1 -
4 of
4The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1??-stimulated synoviocytes of patients with rheumatoid arthritis, Rheumatology International Suppression of pulmonary granulomatous inflammation by immunomodulating agents, Agents and Actions Musculoskeletal update, Inpharma Weekly